Alyeska Investment Group
PHGE icon

Alyeska Investment Group’s BiomX PHGE Stock Holding History

Alyeska Investment Group’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-83,723
Closed -$835K – 700
2025
Q3 		$835K Buy
+83,723
New +$772K ﹤0.01% 545
2025
Q2 		– Sell
-83,723
Closed -$884K – 646
2025
Q1 		$884K Buy
83,723
+38,176
+84% +$533K ﹤0.01% 449
2024
Q4 		$632K Buy
+45,547
New +$649K ﹤0.01% 510

Other funds holding PHGE

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Alyeska Investment Group's PHGE Position: Q4 2025 in Review

Alyeska Investment Group sold out of BiomX (PHGE) in Q4 2025, closing a stake of 83,723 shares — an estimated $835K sold.

Alyeska Investment Group first reported a position in PHGE in Q4 2024 and held it in 3 quarters. The position peaked at $884K in Q1 2025. 11 funds tracked by Wall St. Rank hold PHGE as of Q4 2025.

  • Alyeska Investment Group reported no remaining BiomX position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 83,723 BiomX shares in Q4 2025, an estimated $835K.
  • Alyeska Investment Group first reported a position in BiomX in Q4 2024 and held it in 3 quarters.
  • Alyeska Investment Group's BiomX position peaked at $884K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held BiomX as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.